1. Home
  2. FEED vs OGEN Comparison

FEED vs OGEN Comparison

Compare FEED & OGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

FEED

ENvue Medical Inc. Common Stock

N/A

Current Price

$1.19

Market Cap

4.5M

Sector

N/A

ML Signal

N/A

Logo Oragenics Inc.

OGEN

Oragenics Inc.

HOLD

Current Price

$0.69

Market Cap

3.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FEED
OGEN
Founded
2003
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.5M
3.6M
IPO Year
N/A
2010

Fundamental Metrics

Financial Performance
Metric
FEED
OGEN
Price
$1.19
$0.69
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
316.9K
543.3K
Earning Date
04-06-2026
03-16-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.99
$0.11
52 Week High
$6.09
$9.16

Technical Indicators

Market Signals
Indicator
FEED
OGEN
Relative Strength Index (RSI) 30.61 39.79
Support Level $0.99 $0.61
Resistance Level $3.00 $1.06
Average True Range (ATR) 0.22 0.10
MACD -0.07 -0.02
Stochastic Oscillator 11.11 4.83

Price Performance

Historical Comparison
FEED
OGEN

About OGEN Oragenics Inc.

Oragenics Inc is engaged in the research and development of nasal delivery pharmaceutical medications in neurology and fighting infectious diseases. The company's product ONP-002 is a fully synthetic, non-naturally occurring neurosteroid, is lipophilic, and can cross the blood-brain barrier to rapidly reduce swelling, oxidative stress and inflammation while restoring proper blood flow through gene amplification. The Company operates in one reportable segment, which includes activities related to advancing the development of its concussion drug, ONP-002.

Share on Social Networks: